ENGN NASDAQ
enGene Holdings Inc.
1W: -8.8%
1M: +0.6%
3M: -75.6%
YTD: -80.1%
1Y: -52.4%
$1.76
+0.00 (+0.00%)
Weekly Expected Move ±6.9%
$2
$2
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$90.1M
52W Range1.4-12.25
Volume582,854
Avg Volume1,944,795
Beta-0.28
Dividend$0.70
Analyst Ratings
Company Info
CEORonald H. W. Cooper
Employees82
SectorHealthcare
IndustryBiotechnology
IPO Date2022-02-01
Websiteengene.com
4868 Rue Levy
Montreal, QC H4R 2P1
CA
Montreal, QC H4R 2P1
CA
514 332 4888
About enGene Holdings Inc.
Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy is being developed to treat non-muscle invasive bladder cancer in patients diagnosed with carcinoma-in-situ (Cis) who have shown no improvement after Bacillus Calmette-Guérin therapy. The company was established in 2023 and is headquartered in Saint-Laurent, Canada.
Latest News
This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of enGene Therapeutics Inc. - ENGN
Why Is enGene Therapeutics Stock Falling Friday?
enGene Therapeutics Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Dow Dips 350 Points; US Foods Posts Downbeat Earnings
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Chinoporos Constanti | 75,000 | $1.75 | 2026-07-16 | |
| Richton Kathleen P. | 0 | — | 2026-07-16 | |
| Richton Kathleen P. | 45,000 | $7.39 | 2026-07-16 | |
| Richton Kathleen P. | 13,900 | $9.53 | 2026-07-16 | |
| Richton Kathleen P. | 105,000 | $1.75 | 2026-07-16 |